Georgia vs Macau, China: HIV-positive TB patients on ART (antiretroviral therapy)
Georgia
100.0%
in 2024
Macau, China
100.0%
in 2024
Georgia rank
1st
Macau, China rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Georgia
- Macau, China
How they compare
Georgia currently reports 100.0% against 100.0% in Macau, China, a difference of 0.0%.
The two have swapped places 8 times across 18 shared years of data; in 2005 it was Macau, China ahead.
Georgia ranks 1st and Macau, China ranks 1st of 144 countries.
Georgia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Georgia | Macau, China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 76.0% | 68.8% | 7.2% | Georgia |
| 2010s | 88.7% | 65.3% | 23.3% | Georgia |
| 2020s | 96.6% | 78.4% | 18.2% | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Georgia or Macau, China?
- Georgia, at 100.0% against 100.0% in Macau, China as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Georgia and Macau, China?
- 0.0%, with Georgia ahead.
- How many years of comparable data are there for Georgia and Macau, China?
- 18 years are reported by both, from 2005 to 2024.
- How do Georgia and Macau, China rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Georgia ranks 1st and Macau, China ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.